Works matching DE "HIV protease inhibitors"
Results: 459
Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 9, p. 1297, doi. 10.1007/s00228-021-03108-x
- By:
- Publication type:
- Article
Optimal sampling strategies for darunavir and external validation of the underlying population pharmacokinetic model.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 4, p. 607, doi. 10.1007/s00228-020-03036-2
- By:
- Publication type:
- Article
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients.
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, n. 2, p. 143, doi. 10.1007/s00228-010-0904-4
- By:
- Publication type:
- Article
Identification of NS2B-NS3 Protease Inhibitors for Therapeutic Application in ZIKV Infection: A Pharmacophore-Based High-Throughput Virtual Screening and MD Simulations Approaches.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 131, doi. 10.3390/vaccines11010131
- By:
- Publication type:
- Article
Epoxide Syntheses and Ring-Opening Reactions in Drug Development.
- Published in:
- Catalysts (2073-4344), 2020, v. 10, n. 10, p. 1117, doi. 10.3390/catal10101117
- By:
- Publication type:
- Article
Saquinavir: From HIV to COVID-19 and Cancer Treatment.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/biom12070944
- By:
- Publication type:
- Article
Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.
- Published in:
- HIV Medicine, 2017, v. 18, n. 1, p. 5, doi. 10.1111/hiv.12386
- By:
- Publication type:
- Article
Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.
- Published in:
- HIV Medicine, 2017, v. 18, n. 1, p. 21, doi. 10.1111/hiv.12388
- By:
- Publication type:
- Article
Virological responses to lamivudine or emtricitabine when combined with tenofovir and a protease inhibitor in treatment-naïve HIV-1-infected patients in the Dutch AIDS Therapy Evaluation in the Netherlands ( ATHENA) cohort.
- Published in:
- HIV Medicine, 2016, v. 17, n. 8, p. 571, doi. 10.1111/hiv.12355
- By:
- Publication type:
- Article
Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial.
- Published in:
- HIV Medicine, 2016, v. 17, n. 8, p. 605, doi. 10.1111/hiv.12362
- By:
- Publication type:
- Article
Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials.
- Published in:
- HIV Medicine, 2016, v. 17, n. 5, p. 358, doi. 10.1111/hiv.12348
- By:
- Publication type:
- Article
Heterologous Expression of PKPI and Pin1 Proteinase Inhibitors Enhances Plant Fitness and Broad-Spectrum Resistance to Biotic Threats.
- Published in:
- Frontiers in Plant Science, 2020, v. 11, p. 1, doi. 10.3389/fpls.2020.00461
- By:
- Publication type:
- Article
Correlative iPALM and SEM resolves virus cavity and Gag lattice defects in HIV virions.
- Published in:
- European Biophysics Journal, 2019, v. 48, n. 1, p. 15, doi. 10.1007/s00249-018-1324-0
- By:
- Publication type:
- Article
Synthesis, characterization and catalytic assessment of novel hierarchical zeolite Hβ for the synthesis of biologically active amido alkyl naphthols.
- Published in:
- Research on Chemical Intermediates, 2025, v. 51, n. 3, p. 1187, doi. 10.1007/s11164-024-05484-2
- By:
- Publication type:
- Article
Antiviral Therapy of COVID-19.
- Published in:
- Scripta Medica, 2020, v. 51, n. 3, p. 131, doi. 10.5937/scriptamed51-28336
- By:
- Publication type:
- Article
Powder X-ray diffraction of darunavir ethanolate, C27H37N3O7S(C2H5OH).
- Published in:
- Powder Diffraction, 2015, v. 30, n. 3, p. 298, doi. 10.1017/S0885715615000536
- By:
- Publication type:
- Article
Summaries for patients. Does marijuana affect viral loads in people with HIV?
- Published in:
- 2003
- Publication type:
- journal article
Indinavir and interstitial nephritis.
- Published in:
- 1998
- By:
- Publication type:
- Case Study
Pharmacophore-Based Virtual Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Library of Natural Products.
- Published in:
- Natural Product Communications, 2022, v. 17, n. 12, p. 1, doi. 10.1177/1934578X221143635
- By:
- Publication type:
- Article
Toward the Discovery of SARS-CoV-2 Main Protease Inhibitors: Exploring Therapeutic Potentials of Evodiamine and Its Derivatives, Virtual Screening, Molecular Docking, and Molecular Dynamic Studies.
- Published in:
- Natural Product Communications, 2022, v. 17, n. 12, p. 1, doi. 10.1177/1934578X221143082
- By:
- Publication type:
- Article
Highly Active Antiretroviral Therapy Regimens Protect Against HIV Transmission During Breast-Feeding.
- Published in:
- International Perspectives on Sexual & Reproductive Health, 2010, v. 36, n. 4, p. 209
- By:
- Publication type:
- Article
Darunavir for use in pregnant women with HIV.
- Published in:
- Expert Review of Clinical Pharmacology, 2017, v. 10, n. 12, p. 1317, doi. 10.1080/17512433.2017.1390428
- By:
- Publication type:
- Article
Potential therapeutic target identification in the novel 2019 coronavirus: insight from homology modeling and blind docking study.
- Published in:
- Egyptian Journal of Medical Human Genetics, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s43042-020-00081-5
- By:
- Publication type:
- Article
Consultation psychiatry in COVID‐19 patients: Lopinavir/ritonavir interactions with main psychiatric drugs.
- Published in:
- Psychiatry & Clinical Neurosciences, 2021, v. 75, n. 4, p. 145, doi. 10.1111/pcn.13205
- By:
- Publication type:
- Article
Retraction: Human Epididymis Protein-4 (HE-4): A Novel Cross-Class Protease Inhibitor.
- Published in:
- 2024
- Publication type:
- Correction Notice
Antiviral Medications, Part 2: HIV Antiretroviral Therapy.
- Published in:
- MEDSURG Nursing, 2017, v. 26, n. 5, p. 327
- By:
- Publication type:
- Article
Protease inhibitor treatment in HIV pregnant women. Is it safe for newborns?
- Published in:
- 2002
- By:
- Publication type:
- journal article
The Protease Inhibitor Amprenavir Protects against Pepsin-Induced Esophageal Epithelial Barrier Disruption and Cancer-Associated Changes.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6765, doi. 10.3390/ijms24076765
- By:
- Publication type:
- Article
Discovery of Novel HIV Protease Inhibitors Using Modern Computational Techniques.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12149, doi. 10.3390/ijms232012149
- By:
- Publication type:
- Article
Plant Kunitz Inhibitors and Their Interaction with Proteases: Current and Potential Pharmacological Targets.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Insights into the Role of Tick Salivary Protease Inhibitors during Ectoparasite–Host Crosstalk.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 2, p. 892, doi. 10.3390/ijms22020892
- By:
- Publication type:
- Article
A Computational Approach for the Prediction of Treatment History and the Effectiveness or Failure of Antiretroviral Therapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 3, p. 748, doi. 10.3390/ijms21030748
- By:
- Publication type:
- Article
Serial Femtosecond X-Ray Diffraction of HIV-1 Gag MA-IP6 Microcrystals at Ambient Temperature.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 7, p. 1675, doi. 10.3390/ijms20071675
- By:
- Publication type:
- Article
Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial.
- Published in:
- AIDS Research & Therapy, 2016, p. 1, doi. 10.1186/S12981-016-0101-3
- By:
- Publication type:
- Article
HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users.
- Published in:
- AIDS Research & Therapy, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12981-015-0070-y
- By:
- Publication type:
- Article
ART adherence changes among patients in community substance use treatment: a preliminary analysis from MACH14.
- Published in:
- AIDS Research & Therapy, 2012, v. 9, p. 30, doi. 10.1186/1742-6405-9-30
- By:
- Publication type:
- Article
HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor.
- Published in:
- 2005
- By:
- Publication type:
- journal article
The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Interactions of the protease inhibitor, ritonavir, with common anesthesia drugs.
- Published in:
- Pediatric Anesthesia, 2022, v. 32, n. 10, p. 1091, doi. 10.1111/pan.14529
- By:
- Publication type:
- Article
Anesthesia for children taking COVID‐19 antiviral drugs.
- Published in:
- Pediatric Anesthesia, 2022, v. 32, n. 4, p. 579, doi. 10.1111/pan.14410
- By:
- Publication type:
- Article
The integrated stress response promotes B7H6 expression.
- Published in:
- Journal of Molecular Medicine, 2020, v. 98, n. 1, p. 135, doi. 10.1007/s00109-019-01859-w
- By:
- Publication type:
- Article
Phlorotannins as HIV Vpu inhibitors, an in silico virtual screening study of marine natural products.
- Published in:
- Biotechnology & Applied Biochemistry, 2021, v. 68, n. 4, p. 918, doi. 10.1002/bab.2014
- By:
- Publication type:
- Article
Vanillic acid as phospholipase A<sub>2</sub> and proteases inhibitor: In vitro and computational analyses.
- Published in:
- Biotechnology & Applied Biochemistry, 2021, v. 68, n. 3, p. 486, doi. 10.1002/bab.1943
- By:
- Publication type:
- Article
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 11, p. 2990, doi. 10.1093/jac/dkae319
- By:
- Publication type:
- Article
Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 7, p. 1974, doi. 10.1093/jac/dkac137
- By:
- Publication type:
- Article
Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir: a pharmacokinetic subgroup analysis of the DUALIS study.
- Published in:
- 2020
- By:
- Publication type:
- Letter